ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,273Medicare Part D Prescriptions Filled, Including Refills

Rank: 11 out of 273

$833K Total Retail Price of All Prescriptions

Rank: 18 out of 273

895 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
49% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

2% of this provider’s 895 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

0% of this provider’s 12,475 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $60 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
ATORVASTATIN CALCIUM 1,721 1,486 10 1 8
METOPROLOL SUCCINATE 957 792 2 1
CARVEDILOL 717 528 3 3
BUMETANIDE 682 536 10 4 54
AMLODIPINE BESYLATE 669 594 5 2
LIPITOR 653 535 10 6 29
FUROSEMIDE 644 541 7 5
CLONIDINE HCL 639 550 8 32
DIGOXIN 585 479 9 15
KLOR-CON M20 571 498 10 10 39
LISINOPRIL 472 397 11 4
BYSTOLIC 421 342 12 26
PLAVIX 390 320 13 12
POTASSIUM CHLORIDE 359 302 14 18
HYDRALAZINE HCL 320 268 15 36
ISOSORBIDE MONONITRATE ER 294 194 16 13
CRESTOR 290 219 17 14
BENAZEPRIL HCL 264 204 18 35
CLOPIDOGREL 256 214 19 9
NIASPAN 249 168 20 51
KLOR-CON 10 230 182 21 92
HYDROCHLOROTHIAZIDE 225 171 22 16
WARFARIN SODIUM 219 158 23 7
DIOVAN HCT 214 164 24 58
LOSARTAN-HYDROCHLOROTHIAZIDE 184 164 25 40
BIDIL 180 144 10 26 106
AMIODARONE HCL 149 102 27 23
DIOVAN 149 98 27 21
TERAZOSIN HCL 141 140 29 125
SIMVASTATIN 126 96 30 6
LOSARTAN POTASSIUM 108 88 31 19
LANOXIN 98 96 32 104
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 73 33 38
KLOR-CON M10 95 93 34 120
BENICAR HCT 79 69 35 105
DILTIAZEM ER 78 49 36 66
SPIRONOLACTONE 73 39 37 20
METOLAZONE 65 61 38 94
TRIBENZOR 59 59 39 140
RAMIPRIL 51 36 40 24
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 8, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.